Skin and subcutaneous thickness at injecting sites in children with diabetes: Ultrasound findings and recommendations for giving injection

Pediatric Diabetes

Volumn 13, Issue 7, 2012, Pages 525-533

  Lo Presti, Donatella ^a   Ingegnosi, Carmela ^a   Strauss, Kenneth ^b  

^a Az Policlinico Catania   (Italy)

^b BD   (Belgium)

Author keywords

ID injection; IM injection; Insulin injection; Needle length; SC tissue; Skin thickness

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ABDOMEN; ADOLESCENT; ARTICLE; BODY MASS; BUTTOCK; CHILD; CHILDHOOD DISEASE; CUTANEOUS PARAMETERS; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SKIN SURFACE; SKINFOLD THICKNESS; SUBCUTANEOUS THICKNESS; THIGH;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; NEEDLES; SKIN; SKINFOLD THICKNESS; SUBCUTANEOUS FAT;

EID: 84868202350     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00865.x     Document Type: Article

References (36)

1. Thow JC, Johnson AB, Fulcher G, Home PD. Different absorption of Isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabet Med 1990: 7: 600-602.
2. Frid A, Gunnarsson R, Güntner P, Linde B. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988: 11: 41-45.
3. Owens DR, Coates PA, Luzio SD, Tinbergen JP, Kurzhals R. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Diabetes Care 2000: 23: 813-819.
4. Kolendorf K, Bojsen J, Deekert T. Clinical factors influencing the absorption of 125 I-NPH insulin in diabetic patients. Horm Metab Res 1983: 15: 274-278.
5. Hildebrandt P, Sestoft L, Nielsen SL. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care 1983: 6: 459-462.
6. Vaag A, Pedersen KD, Lauritzen M, Hildebrandt P, Beck-Nielsen H. Intramuscular verse subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabet Med 1990: 7: 335-342.
7. Matsumura M, Monden Y, Nakatani T et al. Improvement of glycemic control by reeducation in insulin injection technique. Diabetes 2007: 56: Abstract 0157-OR.
8. Thow JC, Home PD. Insulin injection technique: depth of injection is important. Br Med J 1990: 301: 3-4.
9. Lasagni C, Seidenari S. Echographic assessment of age-dependent variations of skin thickness. Skin Res Technol 1995: 1: 81-85.
10. Swindle LD, Thomas SG, Freeman M, Delaney PM. View of normal human skin in vivo as observed using fluorescent fiber-optic confocal microscopic imaging. J Invest Dermatol 2003: 121: 706-712.
11. Huzaira M, Rius F, Rajadhyaksha M, Anderson RR, González S. Topographic variations in normal skin, as viewed by in vivo reflectance confocal microscopy. J Invest Dermatol 2001: 116: 846-852.
12. Tan CY, Statham B, Marks R, Payne PA. Skin thickness measured by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol 1982: 106: 657-667.
13. Laurent A, Mistretta F, Bottigioli D et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007: 25: 6423-6430.
14. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010: 26: 1519-1530.
15. Polak M, Beregszaszi M, Belarb Ni et al. Subcutaneous or intramuscular injections of insulin in children. Are we injecting where we think we are? Diabetes Care 1996: 19: 1434-1436.
16. Birkebaek NH, Johansen A, Slovig J. Cutis/subcutis thickness at insulin injection sites and localization of simulated insulin boluses in children with type 1 diabetes mellitus: need for individualization of injection technique? Diabet Med 1998: 15: 965-971.
17. Frid A, Lindén B. Where do lean diabetics inject their insulin? A study using computed tomography. Br Med J 1986: 292: 1638.
18. Burbridge BE. Computed tomographic measurement of gluteal subcutaneous fat thickness in reference to failure of gluteal intramuscular injections. Can Assoc Radiol J 2007: 58: 72-75.
19. Seidenari S, Giusti G, Bertoni L, Magnoni C, Pellacani G. Thickness and echogenicity of the skin in children as assessed by 20-MHz ultrasound. Dermatology 2000: 201: 218-222.
20. Smith CP, Sargent MA, Wilson BP, Price DA. Subcutaneous or intramuscular insulin injections. Arch Dis Child 1991: 66: 879-882.
21. Cash CJC, Berman LH, Treece GM, Gee AH, Prager RW. Two- and three-dimensional ultrasound in the development of a needle-free injection system. Br J Radiol 2004: 77: 236-242.
22. Schou AJ, Thomsen K, Plomgaard AM, Wolthers OD. Methodological aspects of high-frequency ultrasound of skin in children. Skin Res Technol 2004: 10: 200-206.
23. Poland GA, Borrud A, Jacobson RM et al. Determination of deltoid fat pad thickness, implications for needle length in adult immunization. JAMA 1997: 277: 1709-1711.
24. Hofman PL, Lawton SA, Peart JM et al. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents. Diabet Med 2007: 24: 1400-1405.
25. Ploin D, Schwarzenbach F, Dubray C et al. Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children. Vaccine 2011: 29: 8438-8442.
26. Hofman PL, Derraik JG, Pinto TE, Tregurtha S, Faherty A et al. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care 2010: 33: 1940-1944.
27. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L et al. Reduction of the risk of intra-muscular insulin injection with the 8mm length needles in thin diabetic children. Diabetologia 1998: 41 (Suppl. 1): A 247.
28. Tafeit E, Möller R, Jurimae T, Sudi K, Wallner SJ. Subcutaneous adipose tissue topography (SAT-Top) development in children and young adults. Coll Antropol 2007: 31: 395-402.
29. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L et al. Short needles (8mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999: 22: 1621-1625.
30. Birkebaek NH, Solvig J, Hansen B, Jorgensen C, Smedegaard J, Christiansen JS. A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care 2008: 31: e65. doi:10.2337/dc08-0977.
31. Strauss K, De Gols H, Letondeur C, Matyjaszczyk M, Frid A. The Second Injection Technique Event (SITE), May 2000, Barcelona Spain). Pract Diab Int 2002: 19: 17-21.
32. Hirsch L, Klaff L, Bailey T et al. Comparative glycemic control, safety and patient ratings for a new 4mm\32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010: 26: 1531-1541.
33. Strauss K, Hannet I, McGonigle J et al. Ultra-short (5mm) insulin needles: trial results and clinical recommendations. Pract Diab Int. 1999: 16: 22-25.
34. Kreugel G, Keers JC, Jongbloed A, Verweij-Gjaltema AH, Wolffenbuttel BHR. The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009: 58: A117.
35. Schwartz S, Hassman D, Shelmet J et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6mm needle versus a 29 gauge x 12.7mm needle in obese patients with diabetes mellitus. Clin Ther 2004: 26: 1663-1678.
36. Kreugel G, Beijer HJM, Kerstens MN, ter Maaten JC, Sluiter WJ, Boot BS. Influence of needle size for SC insulin administration on metabolic control and patient acceptance. Eur Diabetes Nurs 2007: 4: 1-5.